Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma.

NCT01241162 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT01241162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01241162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma.
Lead sponsor
University of Louisville
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2010
Completion date
October 31, 2016
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewings sarcoma, neuroblastoma, osteogenic sarcoma, rhabdomyosarcoma, synovial sarcoma